Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gordon

Showing results (1081-1090 of 1,291) with videos related to

Pageof 130
Sort By:
JNCI Cancer Spectrum|March 8, 2026
Chronic exercise training intensity, immune cells, and cancer outcomes: a scoping reviewDong-Woo Kang, Kerry S Courneya, Maria C Swartz, et al.
Wellcome Open Research|October 12, 2017
A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, MalawiStephen B Gordon, Jamie Rylance, Amy Luck, et al.
Perioperative Medicine (London, England)|April 13, 2018
Correction to: American Society for Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) Joint Consensus Statement on Optimal Analgesia within an Enhanced Recovery Pathway for Colorectal Surgery: Part 2-From PACU to the Transition HomeMichael J Scott, Matthew D McEvoy, Debra B Gordon, et al.
Journal of Medical Genetics|December 7, 2016
A novel somatic mutation achieves partial rescue in a child with Hutchinson-Gilford progeria syndromeDaniel Z Bar, Martin F Arlt, Joan F Brazier, et al.
Environmental Science & Technology|March 5, 2004
Multilevel cycle of anthropogenic copperT E Graedel, D van Beers, M Bertram, et al.
The Journal of Endocrinology|August 1, 1979
Changes in the concentration of 5-methoxytryptophol in the circulation at different phases of the human menstrual cycleR J Hooper, R E Silman, R M Leone, et al.
Dermatology and Therapy|January 20, 2022
Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge StudyJeffrey J Crowley, Richard G Langley, Kenneth B Gordon, et al.
The Journal of Dermatological Treatment|May 1, 2020
Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trialsK B Gordon, K Reich, J J Crowley, et al.
Journal of Virology|September 29, 2022
Unique Evolution of Antiviral Tetherin in BatsJoshua A Hayward, Mary Tachedjian, Adam Johnson, et al.
Journal of the Endocrine Society|July 7, 2025
Management of Osilodrostat Therapy in Patients With Cushing's Syndrome: A Modified Delphi Consensus PanelSusan L Samson, Diane Donegan, Eliza B Geer, et al.
Pageof 130

Showing results (1081-1090 of 1,291) with videos related to

Sort By:
Pageof 130
JNCI Cancer Spectrum|March 8, 2026
Chronic exercise training intensity, immune cells, and cancer outcomes: a scoping reviewDong-Woo Kang, Kerry S Courneya, Maria C Swartz, et al.
Wellcome Open Research|October 12, 2017
A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, MalawiStephen B Gordon, Jamie Rylance, Amy Luck, et al.
Perioperative Medicine (London, England)|April 13, 2018
Correction to: American Society for Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) Joint Consensus Statement on Optimal Analgesia within an Enhanced Recovery Pathway for Colorectal Surgery: Part 2-From PACU to the Transition HomeMichael J Scott, Matthew D McEvoy, Debra B Gordon, et al.
Journal of Medical Genetics|December 7, 2016
A novel somatic mutation achieves partial rescue in a child with Hutchinson-Gilford progeria syndromeDaniel Z Bar, Martin F Arlt, Joan F Brazier, et al.
Environmental Science & Technology|March 5, 2004
Multilevel cycle of anthropogenic copperT E Graedel, D van Beers, M Bertram, et al.
The Journal of Endocrinology|August 1, 1979
Changes in the concentration of 5-methoxytryptophol in the circulation at different phases of the human menstrual cycleR J Hooper, R E Silman, R M Leone, et al.
Dermatology and Therapy|January 20, 2022
Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge StudyJeffrey J Crowley, Richard G Langley, Kenneth B Gordon, et al.
The Journal of Dermatological Treatment|May 1, 2020
Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trialsK B Gordon, K Reich, J J Crowley, et al.
Journal of Virology|September 29, 2022
Unique Evolution of Antiviral Tetherin in BatsJoshua A Hayward, Mary Tachedjian, Adam Johnson, et al.
Journal of the Endocrine Society|July 7, 2025
Management of Osilodrostat Therapy in Patients With Cushing's Syndrome: A Modified Delphi Consensus PanelSusan L Samson, Diane Donegan, Eliza B Geer, et al.
Pageof 130